Milton Nelson Jr.

Array ( [id] => 10735164 [patent_doc_number] => 20160081314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'Chimeric Antigen Receptors' [patent_app_type] => utility [patent_app_number] => 14/858597 [patent_app_country] => US [patent_app_date] => 2015-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 41971 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14858597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11113576 [patent_doc_number] => 20160310548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF MYOTILIN' [patent_app_type] => utility [patent_app_number] => 14/853517 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11558 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10791853 [patent_doc_number] => 20160138009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'NUCLEIC ACID EXTRACTION USING ORGANIC SOLVENTS TO REMOVE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/845124 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5808 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14845124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14294873 [patent_doc_number] => 10287554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Induced pluripotent stem cell model for Fabry disease and use thereof [patent_app_type] => utility [patent_app_number] => 14/839603 [patent_app_country] => US [patent_app_date] => 2015-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7012 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14839603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10474851 [patent_doc_number] => 20150359868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'Method of Treating Patients with a Mucinous Glycoprotein (MUC-1) Vaccine' [patent_app_type] => utility [patent_app_number] => 14/838018 [patent_app_country] => US [patent_app_date] => 2015-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18182 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12580686 [patent_doc_number] => 20180085391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPHTHALMIC DISEASES AND CONDITIONS [patent_app_type] => utility [patent_app_number] => 15/502368 [patent_app_country] => US [patent_app_date] => 2015-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 100593 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684339 [patent_doc_number] => 20160030484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'MAMMALIAN PLURIPOTENT STEM CELLS, METHODS FOR THEIR PRODUCTION, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/816661 [patent_app_country] => US [patent_app_date] => 2015-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9302 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14816661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10459896 [patent_doc_number] => 20150344910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'METHODS FOR CONTROLLING STEM CELL DIFFERENTIATION' [patent_app_type] => utility [patent_app_number] => 14/816605 [patent_app_country] => US [patent_app_date] => 2015-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 139 [patent_figures_cnt] => 139 [patent_no_of_words] => 41392 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14816605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684333 [patent_doc_number] => 20160030477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'GENE CORRECTION OF SCID-RELATED GENES IN HEMATOPOIETIC STEM AND PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 14/813924 [patent_app_country] => US [patent_app_date] => 2015-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 25792 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14813924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11821851 [patent_doc_number] => 20170210788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-27 [patent_title] => 'MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF INTRABODIES' [patent_app_type] => utility [patent_app_number] => 15/328187 [patent_app_country] => US [patent_app_date] => 2015-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 90281 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430611 [patent_doc_number] => 20150315624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'METHOD OF PRODUCING HETEROGENEOUS PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/800924 [patent_app_country] => US [patent_app_date] => 2015-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18483 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13885497 [patent_doc_number] => 10195280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-05 [patent_title] => Compositions and methods for efficient delivery of molecules to cells [patent_app_type] => utility [patent_app_number] => 14/800565 [patent_app_country] => US [patent_app_date] => 2015-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14339 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11011056 [patent_doc_number] => 20160208009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity' [patent_app_type] => utility [patent_app_number] => 14/796909 [patent_app_country] => US [patent_app_date] => 2015-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17920 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10491565 [patent_doc_number] => 20150376587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'RNA Modification to Engineer Cas9 Activity' [patent_app_type] => utility [patent_app_number] => 14/791200 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 49188 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14791200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11620018 [patent_doc_number] => 20170130206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'Mutant Hemagglutinin Complex Protein, and Method for Culturing Pluripotent Stem Cells Using Same' [patent_app_type] => utility [patent_app_number] => 15/321835 [patent_app_country] => US [patent_app_date] => 2015-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14485 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11729617 [patent_doc_number] => 20170191059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'NUCLEIC ACIDS ACTING AS DECOYS FOR THE TREATMENT OF LENTIVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 15/313151 [patent_app_country] => US [patent_app_date] => 2015-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6113 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10694011 [patent_doc_number] => 20160040157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'MULTI-CHAIN EUKARYOTIC DISPLAY VECTORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/718656 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32186 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14718656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10668868 [patent_doc_number] => 20160015012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'VECTOR CONSTRUCT WITH HUMAN HYPOXIA INDUCIBLE FACTOR ALPHA GENE' [patent_app_type] => utility [patent_app_number] => 14/715343 [patent_app_country] => US [patent_app_date] => 2015-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2903 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13870837 [patent_doc_number] => 20190031759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => CHIMERIC ANTIGEN RECEPTORS AND METHODS OF THEIR USE [patent_app_type] => utility [patent_app_number] => 15/570427 [patent_app_country] => US [patent_app_date] => 2015-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10340721 [patent_doc_number] => 20150225727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'LINEAR DONOR CONSTRUCTS FOR TARGETED INTEGRATION' [patent_app_type] => utility [patent_app_number] => 14/699908 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19724 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699908 [rel_patent_id] =>[rel_patent_doc_number] =>)